Dysregulation of SIRT3 SUMOylation Confers AML Chemoresistance via Controlling HES1-Dependent Fatty Acid Oxidation

Yirong Zhang1, Yajie Shen1,2, Weiqing Wei1

  • 1Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Insights

Sirtuin 3 (SIRT3) SUMOylation regulates chemoresistance in acute myeloid leukemia (AML). Inhibiting SENP1 or overexpressing HES1 enhances chemotherapy efficacy by targeting fatty acid oxidation (FAO) in AML cells.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Sirtuin 3 (SIRT3) deacetylase activity influences chemoresistance in acute myeloid leukemia (AML) by regulating mitochondrial metabolism and reactive oxygen species (ROS).
  • SUMO-specific peptidase 1 (SENP1) enhances SIRT3 deacetylase activity through de-SUMOylation.
  • Dysregulation of SIRT3 SUMOylation is implicated in AML chemoresistance.

Purpose of the Study:

  • To investigate the role of SIRT3 SUMOylation in regulating chemoresistance in acute myeloid leukemia (AML).
  • To explore the underlying mechanisms involving fatty acid oxidation (FAO) and the Notch1 signaling pathway.
  • To evaluate potential therapeutic strategies targeting SIRT3 SUMOylation and FAO in AML.

Main Methods:

  • RNA sequencing (RNA-seq) to analyze gene expression changes.
  • In vitro and in vivo experiments using AML cell lines and xenograft mouse models.
  • Assessment of SIRT3 de-SUMOylation, HES1 expression, and FAO levels.
  • Evaluation of drug synergy with cytarabine.

Main Results:

  • Chemotherapeutic agents induced SIRT3 de-SUMOylation, increasing AML chemoresistance by preventing proteasome degradation.
  • SIRT3 de-SUMOylation altered gene expression, inhibiting Hes Family BHLH Transcription Factor 1 (HES1) and increasing fatty acid oxidation (FAO).
  • SENP1 inhibition (momordin-Ic) or HES1 overexpression synergized with cytarabine to eradicate AML cells.

Conclusions:

  • SIRT3 SUMOylation plays a novel role in regulating AML chemoresistance through HES1-dependent FAO.
  • Targeting SIRT3 SUMOylation and FAO presents a promising therapeutic strategy to enhance AML chemotherapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
7.0K